baber/WOPTO huggingface dataset:
Patent FI-942070-A0 (FI)
Inventor: ISHIHARA SADAO
IPC: C07D307/68
Filed: 1994-05-05
Abstract: Constitution: a nitroxyalkylamide derivative represented by the general formula (I): R<1>-(A)n-COHN-B-ONO2, wherein R<1> represents optionally substituted heterocyclic, heterocyclic oxy, aryloxy or arylthio; A represents C1-C4 alkylene; B represents C1-C4 alkylene; and n represents 0 or 1. Effect: this compound is excellent in collateral vasodilatory and antianginal activities and hence is useful as a remedy for angina pectoris.
Patent FI-944550-A0 (FI)
Inventor: MOLONEY MAURICE M
IPC: C07K14/415
Filed: 1994-09-30
Abstract: PCT No. PCT/CA93/00141 Sec. 371 Date Jan. 27, 1995 Sec. 102(e) Date Jan. 27, 1995 PCT Filed Apr. 2, 1993 PCT Pub. No. WO93/20216 PCT Pub. Date Oct. 14, 1993DNA constructs comprising 5' untranslated sequences from genes active from the late globular stage through to embryo maturity are provided. These constructs may be used to obtain expression of a DNA sequence of interest during phases of embryogenesis which precede the accumulation of storage proteins.
Patent FI-944631-A0 (FI)
Inventor: MYREEN BERTEL
IPC: C02F9/00
Filed: 1994-10-04
Abstract: A method for essentially complete oxidation of concentrated liquors containing oxidable organic matter is disclosed. The following steps are performed under substantial superatmospheric pressure in the method: a feed of the concentrated liquor (8) is brought into direct contact (7) with a hot gas (5) for heating and evaporation of said liquor to produce a final concentrate (11) suitable for oxidation and at a temperature close to its boiling point, and to quench the hot gas to a temperature not more than 100  DEG C above the final conconcentrate boiling point at the prevailing superatmospheric pressure, the final concentrate (11) is oxidised (1) essentially completely at a temperature of at least 800  DEG C with a gas (13) containing at least 60 per cent by volume of oxygen resulting in a suspension of hot gas (5) and molten slag (6), and the molten slag is separated (6) from the hot gas and dissolved in water (15).
Patent FI-971312-A0 (FI)
Inventor: BATT DOUGLAS GUY
IPC: A61K31/19
Filed: 1997-03-27
Abstract: This invention relates to ortho substituted phenyl compounds as inhibitors of prostaglandin synthase, to pharmaceutical compositions comprising such compounds and to methods of using such compounds as antiinflammatory and antipyretic agents. The class of compounds useful in this method of treatment is represented by Formula I below:    <IMAGE>  (I)
Patent FI-972238-A0 (FI)
Inventor: SOOKNANAN ROY
IPC: C12Q1/68
Filed: 1997-05-27
Abstract: This invention relates to a process for amplifying a specific nucleic acid sequence or its complement at a relatively constant temperature and without serial addition of reagents. The process provides in a single reaction medium an RNA polymerase, DNA polymerase, a ribonuclease that hydrolyses RNA of an RNA-DNA hybrid without hydrolysing single or double-stranded RNA or DNA, and ribonucleoside and deoxyribonucleoside triphosphates. The process then provides an RNA first template in the reaction medium. The RNA first template comprises a sequence complementary to a specific nucleic acid sequence, minus-sense sequences for a promoter and initiation site that are recognized by the RNA polymerase, and a 5'-terminal sequence that is complementary to at least the minus-sense sequence of the initiation site. Thus, the RNA first template has an inverted repeat sequence which could fold into a 5'-terminal stem-loop structure. The DNA polymerase uses the RNA first template to synthesize a DNA second template that together comprise an RNA-DNA hybrid. The DNA second template has plus-sense sequences of the promoter and the initiation site, and a 3'-terminal priming sequence that is complementary to the plus-sense sequence of the initiation site. The ribonuclease then hydrolyses an RNA which comprises the RNA-DNA hybrid, allowing the 3'-terminal priming sequence to hybridize to the plus-sense sequence of the initiation site in the DNA second template. The DNA polymerase then uses the DNA second template to synthesize the promoter by extending the 3'-terminal priming sequence of the DNA second template. The resulting partially double-stranded DNA has a promoter oriented toward the apex of a stem-loop structure. The RNA polymerase then recognizes the promoter and transcribes the DNA second template, thereby providing copies of the RNA first template. The process thereafter maintains the reaction conditions for a time sufficient to achieve a desired amplification of the specific nucleic acid sequence or its complement. This invention includes a kit containing the reagents of this invention.
Patent IL-70082-A0 (IL)
Title: 1-aroyl-5-oxo-2-pyrrolidinepropanoic acids and salts and esters thereof,their preparation and pharmaceutical compositions containing them
IPC: C07D207/27
Filed: 1983-10-28
Abstract: 1-Aroyl-5-oxo-2-pyrrolidinepropanoic acids, salts, and esters which are useful as pharmacological agents, especially as agents for the reversal of amnesia, enhancing performance in poorly motivated subjects and treatment of senility and methods for their preparations are disclosed. Pharmaceutical compositions containing said compounds, salts, and esters and methods for using said compositions in treating senility, improving motivation and reversal of amnesia are also taught. The novel compounds have the formula:where R, X and Y are hydrogen atoms or various substituents, but R, X and Y are not simultaneously all hydrogen atoms.
Patent IL-70095-A0 (IL)
Title: Preparation of 1,1-dioxopenicillanoyloxymethyl 6beta-aminopenicillanate and novel intermediates used therefor
IPC: C07D519/00
Filed: 1983-10-31
Abstract: A process for the preparation of 1,1-dioxopenicillanoyloxymethyl 6-beta-aminopenicillanate which comprises reacting 1,1-dioxopenicillanoyloxymethyl 6-phenylacetamidopenicillante or the corresponding phenoxy- acetamidopenicillanate under anhydrous conditions with a halogenating agent in the presence of a reaction inert solvent to form an intermediate imino halide, addition of a primary alcohol having from one to four carbon atoms to convert the imino halide to an imino ether and subsequent hydrolysis to give the desired product.
Patent IL-83044-A0 (IL)
Title: Diphenylpropanamines,their preparation and pharmaceutical compositions containing them
IPC: C07C27/00
Filed: 1987-07-01
Abstract: Diphenylpropylamine derivatives of the formula I 
<IMAGE>
 in which:
 R<1> denotes hydrogen or methyl,
 R<2> denotes hydrogen, methyl or n-decyl,
 Z (a) denotes a phenyl group substituted by R<3>, R<4> and R<5>, in which:
 R<3> denotes hydrogen, fluorine, chlorine or bromine, nitro, C1-12-alkyl, C1-4-alkoxy, phenoxy or benzyloxy,
 R<4> and R<5> denotes hydrogen, chlorine, hydroxyl, alkoxy, benzyloxy, acetamido or carboxyl or
 R<4> and R<5> together denote methylenedioxy or
 (b) denotes 4-methoxynaphthyl or 4-ethoxynaphthyl, and R<6> denotes hydrogen or fluorine, with the proviso that R<1>, R<2>, R<3>, R<4>, R<5> and R<6> do not simultaneously denote hydrogen atoms,
 and their physiologically tolerable acid addition salts are used as active substances in pharmaceutical agents which can primarily be advantageously used for the therapy of cardiac and circulatory disorders.
Patent IL-83586-A0 (IL)
Title: Substituted hexahydroarylquinolizines and pharmaceutical compositions containing them
IPC: C07D471/22
Filed: 1987-08-19
Abstract: Certain substituted hexahydroarylquinolizines and pharmaceutically acceptable salts thereof are peripherally selective  alpha 2-adrenoceptor antagonists. The compounds are adapted to be employed for the treatment of certain pathological disorders such as hypertension, diabetes, disorders involving platelet aggregation and the like without side effects attributable to effect on the central nervous system.
Patent IL-93714-A0 (IL)
Title: Guidewire exchange catheter
IPC: A61M25/08
Filed: 1990-03-12
Abstract: A catheter (10) for facilitating the exchange of guidewires during the course of a transluminal angioplasty or related procedure which comprises an elongated, flexible, tubular member (12) having at least one lumen (18) running the full length thereof from its proximal end (14) to its distal end (16) and with at least three apertures (20, 22, 24) or ports extending through the wall thereof at longitudinally spaced locations near the distal end (16) of the tubular member (12). These ports (20, 22, 24) communicate with the lumen (18) of the tubular member (12) and a longitudinal slit (26) is also provided through the wall of the tubular member (12) connecting the most proximal port (20) to the next proximal port (22). The exchange catheter (10) may also include a proximal hub (28) connected to the proximal end (14) of the elongated plastic tube (12).
Patent SE-9901841-A0 (SE)
Title: Vätskeskiljande anordning inrättad att förhindra en vätska i en behållare från att sugas in i en vakuumledning
Inventor: PERSSON STAFFAN
IPC: B01D45/08
Filed: 1999-05-20
Abstract: mjolkledningarna. Nar vatska fran flera mjolkledningar nar behallaren riskerar sadana vagor att motas i behallaren med ett kraftigt vatskestank som MIA. Vatska som stanker uppat riskerar darmed att sugas in i vakuumledningen. 'fall vatska sugs in i va5 kuumledningen kan vakuumpumpen skadas. Den vatskeavskiljande anordningen innehaller ett i vatska flytbart stangningsorgan som är inrattat att stanga till vakuumledningens anslutningsOppning ifall vatskenivan i den vatskeavskiljande an- ordningen stiger over en bestarnd niva, vilket kan intraffa om ex- empelvis ett fel uppstar i myilkningsanlaggningen. Nar mjOlkningsanlaggningen startar och vakuumledningen upprattar ett undertryck i behallare och mjtilkledningar bildas inledningsvis ofta ett kraftigt, stOtliknande gasflode av dari befintlig luft, vilken strommar genom behallaren och den vatskeavskiljande anordningen till vakuumledningen. Pa grund av detta stOtliknande gasflOde riskerar stangningsorganet hos den vatskeavskiljande anordningen att dras med av gasflOdet och forskjutas uppat. FOrskjuts stangningsorganet tillrackligt Mgt uppat kommer det att stanga till vakuumledningens anslutningsoppning. Den vatskeav- skiljande anordningen maste saledes aven av denna anledningen uppvisa en tillracklig utstrackning i hojdled. Vid manga moderna mjalkningsanlaggningar stalls dock krav pa att behallarens och den vatskeavskiljande anordning totala hojd ska reduceras. SAMMANFATTNING AV UPPFINNINGEN Syftet med foreliggande uppfinning är att tillhandahalla en be- hallare och en vatskeavskiljande anordning av inledningsvis narnnt slag, vilka har en sadan konstruktion att de tillsammans uppvisar en relativt lag totalhojd.
Patent AU-PR343701-A0 (AU)
Title: pH adjustment in the flotation of sulphide minerals
IPC: B03D1/02
Filed: 2001-02-28
Abstract: The present invention relates generally to a process for flotation of sulphide minerals where a flotation pulp is separated into a coarse stream and a fine stream, preferably containing particles coarser than about 30 micron and particles finer than about 30 micron, respectively. Typically, alkali and depressant are added to the coarse flotation stream only and acid and activator are added to the fine flotation stream only. During flotation of the fine stream, acid and/or activator may be added at the conditioning, cleaning, re-cleaning, cleaner-scavenging or third cleaning stage. During flotation of the coarse stream, alkali and/or depressant may be added at the conditioning or cleaning stage.
Patent FI-20010543-A0 (FI)
Inventor: KOKKONEN MIKKO
IPC: G01S1/00
Filed: 2001-03-16
Abstract: The reference values are formed based on a received repetition coded signal. Vectors are formed using the reference values such that the number of vector elements corresponds to the number of symbols used in transmission of the bits. The largest of the elements of a determination vector formed by combining the vectors, is determined and the index of the largest element is used to indicate the bit boundary.  Independent claims are included for the following:  (1) Bit boundary detection system; and  (2) Electronic device.
Patent FI-20020951-A0 (FI)
Inventor: MOILALA KARI
IPC: F24F3/14
Filed: 2002-05-21
Abstract: The invention relates to an air conditioning device consisting of recovery cells (1, 2), an inlet (3) and exhaust ducts (4) leading to and from a room, an inlet (5) and exhaust ducts (6), the air flown in the air conditioning device being controlled by means of rotating deflectros (7, 8). The deflectors (7, 8) consists of baffles fixed to rotate, the air openings (9, 10) provided in the deflectors being located alternatingly at the same recovery cell (1, 2), where the air flow directions are reversed periodically.
Patent IL-100101-A0 (IL)
Title: 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics,and a process for preparing them
IPC: A61P31/04
Filed: 1991-11-20
Abstract: The present invention is directed to novel 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antiobiotics and a process for preparing them which includes submitted the corresponding lower alkyl ester precursor to a reduction reaction in the presence of an alkali metal borohydride. The compounds of the invention show an improved antibacterial activity against some clinical isolates of Staphylococci somewhat resistant to teicoplanin. The teicoplanin derivatives of the present invention are represented by the following formula:   <IMAGE>   wherein: X represents hydroxymethyl; R represents hydrogen or -N[(C9-C12)aliphatic acyl]- beta -D-2-deoxy-2-aminoglucopyranosyl; R1 represents hydrogen or N-acetyl- beta -D-2-deoxy-2-aminoglucopyranosyl; R2 represents hydrogen of alpha-D-mannopyranosyl; R3 represents hydrogen or a protecting group of the amino function; and the acid addition salts thereof; with the proviso that R1 represents hydrogen only when R and R2 are simultaneously hydrogen.
Patent IL-100625-A0 (IL)
Title: Electrically and mechanically rechargeable zinc/air battery
IPC: H01M4/75
Filed: 1992-01-10
Abstract: The invention provides an electrochemical metal-air cell, adapted for multiple discharge and recharge cycles, comprising a housing defining an interior space for containing therein a replaceable metal electrode having a generally planar electrically conductive skeletal member encompassed by an active metal component; at least one generally planar air permeable but liquid impermeable air electrode installed at at-least one of the sides of the housing; an electrolyte in contact with the metal and the air electrodes; and further comprising one or more auxiliary electrodes, each auxiliary electrode constituting a charging anode adapted to be engaged upon application of electric current thereto for effecting the reduction and regeneration of the active metal component in a first mode of operation, during which the air electrode is disengaged, and to be disengaged in a second mode of operation, wherein the metal electrode is configured for removal from the interior space to enable the mechanical replacement thereof as well as being rechargeable in situ by the application of electric current to the auxiliary charging anode to reduce oxidized active metal thereof. <IMAGE>
Patent IL-107060-A0 (IL)
Title: Intimate cleaning assembly
IPC: B65D81/32
Filed: 1993-09-21
Abstract: This invention discloses a cleaning assembly comprising a wet tissue, a liquid impermeable packet containing the wet tissue and a dry liquid absorbent tissue mounted onto the liquid impermeable packet. <IMAGE>
Patent IL-109823-A0 (IL)
Title: Method to butt bars, and bar butting assembly that employs such method
IPC: B21D43/00
Filed: 1994-05-30
Abstract: Butting assembly to butt a single bar (11) or to butt a bundle of bars (11) by butting the single bars (11), the assembly being installed upstream of a processing machine, the bars (11) being fed one by one by hand or automatically to the butting assembly, which comprises a trolley (12) capable of to-and-fro alternating motion and able to move along a guide (13) extending lengthwise along the axis of the bar (11), the trolley (12) including at its upstream end gripper means (15) and at its downstream end abutment plate means (14) on the same axis as the bar (11), the abutment plate means (14) being kept resiliently in an inactive position and cooperating directly with position detection means (16) associated with an assembly (17) that manages and controls the butting assembly (10), the extreme positions of the trolley (12) being defined on the guide (19) by two end-of-travel stops (19), which are an upstream end-of-travel stop (19a) and a downstream end-of-travel stop (19b) respectively, the downstream end-of-travel stop (19b) actuating the gripper means (15) for opening and release. Butting method which employs the butting assembly (10) of Claims 1 and 2 and includes the following steps: <24) -   feeding a bar (11) to be butted which is upheld on supporting means (31) in their working position (31a); <25) - upstream retreat of a trolley (12); <26) -   checking whether there is contact between the leading end of the bar (11) and abutment plate means (14);       (A) - if the answer to check (26) is yes: <27) -   closure of gripper means (15); <28) -   disactivation of the supporting means (31); <29) -   downstream advance of the trolley (12), with the bar (11) clamped by the gripper means (15), to a downstream end-of-travel stop (19b); <30) -   opening of the gripper means (15) with resulting discharge of the butted bar (11); <32) - activation of the supporting means (31);     (B) - if the answer to check (26) is no: <27) -   closure of the gripper means (15); <22) -   downstream advance of the trolley (12), with the bar (11) clamped by the gripper means (15), to a downstream end-of-travel stop (19b); <21) - opening of the gripper means (15) with resulting release of the unbutted bar (11), which remains upheld by the supporting means (31) in their working position (31a); <25) -   upstream retreat of the trolley (12) and repetition of the cycle from step (26) onwards.     <IMAGE>
Patent IL-112049-A0 (IL)
Title: Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism
IPC: C07D333/56
Filed: 1994-12-19
Abstract: A method of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism comprising administering to a human in need thereof an effective amount of a compound having the formula <CHEM>     wherein R<1> and R<3> are independently hydrogen, -CH3, <CHEM>  wherein Ar is optionally substituted phenyl; R<2> is selected from the group consisting of pyrrolidine, hexamethyleneamino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
Patent IL-112288-A0 (IL)
Title: Application of riluzole in the treatment of mitochondrial diseases
IPC: A61P25/28
Filed: 1995-01-09
Abstract: PCT No. PCT/FR95/00023 Sec. 371 Date Jul. 11, 1996 Sec. 102(e) Date Jul. 11, 1996 PCT Filed Jan. 9, 1995 PCT Pub. No. WO95/19170 PCT Pub. Date Jul. 20, 1995A method for the treatment of mitochondrial diseases, including Kearns-Sayre syndrome, MERRF syndrome, MELAS syndrome and Leber's disease, is carried out by administering to a patient in need of treatment an effective amount of riluzole or a pharmaceutically acceptable salt thereof.
Patent IL-113569-A0 (IL)
Title: An analytical system for monitoring a substance to be analyzed in patient-blood
IPC: A61B5/1455
Filed: 1995-05-01
Abstract: The blood analysis system is used to monitor the glucose conc. of the blood using a sensor unit (2) attached to the body of the patient, with a sensor (7) measuring a parameter which is dependent on the glucose conc. and a transmitter for transmitting the obtained data to a central evaluation unit (3). Pref. the sensor unit uses light for detecting a physical parameter dependent on the glucose conc., the evaluation unit calibrating the received data with analysis data for the analysis element, held in a memory, to control a read-out display (21). <IMAGE>
Patent IL-133150-A0 (IL)
Title: Process for the preparation of 1-(3,4-dimethoxyphenyl) ethanol
IPC: C07B61/00
Filed: 1998-07-28
Abstract: The subject of our invention is the process for the preparation of the 1-(3,4-dimethoxyphenyl)ethanol of formula (I), by the reduction of 3,4-dimethoxyacetophenone of formula (II), characterized in that the carbonyl group of the 3,4-dimethoxyacetophenone of formula (II) is reduced by 1 mol of hydrogen under the conditions of catalytic hydrogenation.
Patent IL-134146-A0 (IL)
Title: Digital transport stream piocessing
IPC: H04N21/434
Filed: 1998-07-23
Abstract: A device for use in a receiver/decoder for a broadcast digital television system in which received signals are passed through a receiver to the receiver/decoder and thence to a television set. The receiver/decoder decodes a compressed MPEG-type signal, and is controlled by a remote controller handset, through an interface in the receiver/decoder. The receiver/decoder includes a plurality of interfaces to external units, and logical driver devices for the interfaces. The device produces a partial transport stream or an encapsulated data stream from the received broadcast digital data stream under the control of an application. This may allow a desired data stream, for example containing selected programmes to be recorded by a digital video recorder coupled to receive the output of the device or may facilitate communication with a computer. <IMAGE>
Patent IL-137608-A0 (IL)
Title: Use of 2-amino-6- trifluoromethoxy-benzothiazole for preventing or treating cerebellum dysfunction
IPC: C07D277/82
Filed: 1999-02-03
Abstract: A method for the prevention or treatment of cerebellar dysfunction, particularly cerebellar ataxia, by the use of riluzole or a pharmaceutically acceptable salt thereof.
Patent IL-142269-A0 (IL)
Title: Process for recovering heterologous polypetides from bacterial cells
IPC: C07K16/28
Filed: 1999-10-21
Abstract: The present invention relates to processes for recovering heterologous polypeptides from bacterial cells, including the periplasm and cytoplasm. The processes involve culturing the bacterial cells, which cells comprise nucleic acid encoding phage lysozyme and nucleic acid encoding a protein that displays DNA-digesting activity, wherein these nucleic acids are linked to a first promoter, and nucleic acid encoding the heterologous polypeptide, which nucleic acid is linked to a second promoter, under certain conditions to produce a broth lysate; and recovering accumulated heterologous polypeptide from the broth lysate. <IMAGE>
Patent IL-144971-A0 (IL)
Title: Wireless communication network including plural migratory access nodes
IPC: H04L12/28
Filed: 2000-02-17
Abstract: An amorphous communication network having no traditional wireless backbone has plural roving or migratory access node or terminal devices that are carried or transported along with individuals. Each wireless node has a user interface and a local ID, e.g., an IP address, URL, telephone number. Voice, data, or video is transferred to other migratory nodes or to a conventional land-based telephone or data terminal via a PSTN, Internet, ATM network, etc. A geolocation detector in the node, such as a GPS, keeps track of the instantaneous position, which is conveyed to a locally or remotely stored database. A local processor accesses this database to determine node-to-node paths to a destination when said node operates as a source. A node captures a transmitted message when the destination address in the message matches its local address, or otherwise forwards the message towards a destination if the address does not match. Acknowledgements are sent between nodes upon successful receipt of information. The node's wireless transceiver also adapts to the environment and terrain to control transmission and reception characteristics according to bandwidth, inter-node spacing, signal strength, bit error rate, node population density, frequency spectrum, data rate and/or air interface protocol. Nodes may periodically or randomly unicast or broadcast its ID and/or position data to update a database, which then may be propagated to other databases throughout the network. A database may reside locally within a node or at fixed regional locations that are linked together to form a global database.